Skip to main content
. 2024 Dec 5;6:61. doi: 10.1186/s42836-024-00282-y

Table 3.

Summary of results

Characteristic n (%) Success
(%)
Odds ratio (95 confidence interval), P-value
Unadjusted Adjusted
Age
Minimum–Maximum 37.3–92.4 - 1.00 (0.96–1.05), 0.900 -
Median (LQ–UQ) 70 (59–78)
Mean (Standard deviation) 68.7 (12.6)
Gender
Male 39 (60.9) 28 (71.8) -
Female 25 (39.1) 16 (64.0) 0.70 (0.24–2.04), 0.512
Surgeon 0.339 0.303
Arthroplasty 24 (37.5) 19 (79.2) Reference category Reference category
Revision 26 (40.6) 17 (65.4) 0.50 (0.14–1.78), 0.282 0.46 (0.10–2.15), 0.326
Non-arthroplasty 14 (21.9) 8 (60.0) 0.35 (0.08–1.49), 0.156 0.28 (0.05–1.48), 0.134
Organism prior to DAIR
No 41 (64.1) 28 (68.3) -
Yes 23 (35.9) 16 (69.6) 1.06 (0.35–3.20), 0.916
Symptom duration
 ≤ 1 Week 20 (31.7) 18 (90.0) Reference category
 > 1 Week 43 (68.3) 25 (58.1) 0.15 (0.03–0.75), 0.021 0.11 (0.02–0.78), 0.027
KLIC score 0.057 0.066
0–2 21 (32.8) 13 (61.9) Reference category Reference category
2.5–3.5 11 (17.2) 8 (72.7) 1.64 (0.33–8.07), 0.542 1.48 (0.25–8.57), 0.664
4–5 20 (31.3) 18 (90.0) 5.54 (1.01–30.5), 0.049 3.76 (0.58–24.3), 0.164
5.5–8.0 12 (18.8) 5 (41.7) 0.44 (0.10–1.87), 0.265 0.21 (0.03–1.54), 0.126